Palantir Technologies Inc. (PLTR) partners with OneMedNet Corp. (ONMD) to enhance healthcare AI and data analytics using Palantir’s Artificial Intelligence Platform (AIP). The collaboration will accelerate real-world imaging data use in clinical research, covering over five billion administrative claims and 131 million clinical exams.

This partnership strengthens Palantir’s presence in healthcare and life sciences, showcasing its credibility in regulated health data handling. The company aims to lead the AI-driven transformation of biomedical data management. Palantir’s U.S. commercial revenue grew 93% YoY, with a customer count increase of 64%, projecting revenue guidance exceeding $1.302 billion.

PLTR stock draws institutional interest, with analysts projecting a consensus price target of $141.28. Despite a 20% downside from its recent closing price, Palantir’s contracts like the one with OneMedNet demonstrate its premium value. Bullish options activity signals confidence before earnings, with traders positioning for continued upside momentum despite increased short interest.

Read more at Nasdaq: Palantir’s New Healthcare Deal Boosts AI and Data Reach